A new perspective in pyroptosis: lifting the veil on GSDMA activation

References

[1] Broz P, Pelegrín P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol 2020; 20(3): 143–157

[2] Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol 2017; 27(9): 673–684

[3] Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 2021; 6(1): 128

[4] Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 2011; 9(10): 724–736

[5] Weckel A, Guilbert T, Lambert C, Plainvert C, Goffinet F, Poyart C, Méhats C, Fouet A. Streptococcus pyogenes infects human endometrium by limiting the innate immune response. J Clin Invest 2021; 131(4): 130746

[6] Deng W, Bai Y, Deng F, Pan Y, Mei S, Zheng Z, Min R, Wu Z, Li W, Miao R, Zhang Z, Kupper TS, Lieberman J, Liu X. Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis. Nature 2022; 602(7897): 496–502

[7] LaRock DL, Johnson AF, Wilde S, Sands JS, Monteiro MP, LaRock CN. Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes. Nature 2022; 605(7910): 527–531

[8] Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci 2017; 42(4): 245–254

[9] Liu X, Xia S, Zhang Z, Wu H, Lieberman J. Channelling inflammation: gasdermins in physiology and disease. Nat Rev Drug Discov 2021; 20(5): 384–405

RIGHTS & PERMISSIONS

Higher Education Press